
Genprex IncQ) expected to post a loss of 39 cents a share - Earnings Preview

Genprex IncQ) is expected to report a loss of 39 cents per share for the period ending December 31, 2024, with results anticipated on March 31. The mean earnings estimate has remained unchanged over the last three months. Currently, there is one analyst rating, which is a "buy." Wall Street's median 12-month price target for the company is $7.50, significantly higher than its last closing price of $0.34.
Genprex Inc (GNPX.OQ) (GNPX.O) is expected to report results on March 31 (estimated) for the period ending December 31 2024
LSEG’s mean analyst estimate for Genprex Inc is for a loss of 39 cents per share.
The one available analyst rating on the shares is “buy”.
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street’s median 12-month price target for Genprex Inc is $7.50, above its last closing price of $0.34. This summary was machine generated March 28 at 20:35 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
